A lot of patients wind up in a maxillofacial consult for the first time in their adult lives after a year on a GLP-1, and theyre not imagining things
Only the brand-name versions manufactured by Novo Nordisk (Ozempic, Wegovy, and Rybelsus) have received FDA approval
Lightheadedness is typically most pronounced during the initial weeks of tirzepatide therapy or following dose escalation, often improving as the body adjusts over several days to weeks
Use two times a day, specifically in the morning and evening
Swap that GLP-1 component for a more potent triple agonist like Retatrutide and the mechanistic ceiling, at least on paper, sits higher still
Nevertheless, the neurochemical mechanism of early response is poorly understood, precluding efforts to prevent or reduce the rates of treatment failure and persistent disability